Discovery Science
Mayo Clinic researchers and collaborators zeroed in on the mechanism by which different forms of a protein associated with frontotemporal dementia could affect disease risk and severity. Their research could lead to new therapies in the future.
Latest stories
COVID-19
November 30, 2020
Biotherapeutics
November 28, 2020
Research
November 25, 2020
Featured News
November 24, 2020
Clinical Trials
November 23, 2020
Cancer
November 21, 2020
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community